AI Article Synopsis

  • - The study aimed to compare the effectiveness of combined therapy with probiotics and cytokine-induced killer (CIK) cells against colorectal cancer (CRC) growth and metastasis in mice versus using either treatment alone.
  • - Results showed that both probiotics and CIK cells significantly reduced CRC cell viability and increased apoptosis, with the combination of both therapies being the most effective at suppressing tumor growth and metastasis.
  • - Mice treated with combined probiotics and CIK therapy exhibited the least amount of tumor presence and related biomarkers in the liver compared to the other treatment groups, indicating a stronger anti-cancer effect.

Article Abstract

This study tested the hypothesis that combined therapy with probiotics and cytokine-induced killer (CIK) cells was superior to merely one on suppressing the peritoneal carcinomatosis and liver metastasis of colorectal cancer (CRC) cells in nude mice. The study revealed that in HCT 116/SW620 CRC cell lines, cell viability, proliferation, colony formation, migratory ability, wound healing, and protein expression of PD-L1 and FAK were significantly and comparably suppressed and that apoptosis was significantly and comparably increased by probiotics and CIK cells, and these effects were further significantly enhanced by combined probiotics + CIK cell therapy (all p<0.001). Nude mice were categorized into Groups 1 (SC), 2 (HCT 116), 3 (HCT 116 + probiotics), 4 (HCT 116 + CIK cells), and 5 (HCT 116 + probiotics + CIK cells). CRC cells were intraperitoneally implanted into Groups 2 to 5, and the animals were euthanized by Day 28. The results demonstrated that the abdominal dissemination of CRC cells, tumor numbers, tumor weights, liver weights, liver necrosis areas and the expression of γ-H2AX/PD-L1/FAK in harvested liver tumors were lowest in Group 1, highest in Group 2, and significantly and progressively decreased in Groups 3 to 5 (all p<0.0001). The protein expression levels of apoptotic and DNA damage biomarkers (Bax/c-caspase 3/c-PARP/γ-H2AX), a metastatic biomarker (FAK) and three tumor proliferation and survival signaling biomarkers (JAK-STAT1, PI3K/Akt/m-TOR and Ras/Raf/MEK/ERK) exhibited identical patterns to that of a tumor immune escape biomarker (PD-L1) among the groups (all p<0.0001). The combination of probiotics and CIK cells was superior to either therapy alone in suppressing CRC cell growth, proliferation, liver metastasis and survival, mainly through downregulating cell proliferation and survival signaling pathways.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11628340PMC
http://dx.doi.org/10.7150/ijbs.101051DOI Listing

Publication Analysis

Top Keywords

cytokine-induced killer
8
peritoneal carcinomatosis
8
carcinomatosis liver
8
liver metastasis
8
metastasis colorectal
8
colorectal cancer
8
cik cells
8
probiotics cik
8
cells
5
probiotic-facilitated cytokine-induced
4

Similar Publications

Background: Immunotherapy utilizing dendritic cells (DCs) and cytokine-induced killer (CIK) cells is a promising treatment approach for solid tumors. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of DC-CIK immunotherapy by assessing overall survival, progression-free survival, overall response rate, disease control rate, and adverse events in relevant randomized controlled trials. The results of this analysis will contribute to optimizing treatment strategies and improving cancer immunotherapy outcomes.

View Article and Find Full Text PDF

Long-term survival after local immunotherapy for malignant gliomas: a retrospective study with 20 years follow-up.

BMC Immunol

December 2024

Department of Neurosurgery/Neuro-Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.

Purpose: Immunotherapy is a promising treatment for cancers but should be optimized for malignant gliomas. Because of immune privilege feature of the brain, local administration of immunotherapy may be a promising strategy for malignant glioma treatment. Identification of patients who may benefit from local immunotherapy is essential.

View Article and Find Full Text PDF

DNMT1 inhibition improves the activity of memory-like natural killer cells by enhancing the level of autophagy.

Mol Biol Rep

December 2024

Yunnan Key Laboratory of Laboratory Medicine, Yunnan Province Clinical Research Center for Laboratory Medicine, Department of Clinical Laboratory, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.

Background: Acute myeloid leukemia (AML) is a common hematological tumor, but it is difficult to treat. DNMT1 is a DNA methyltransferase whose main function is to maintain stable DNA methylation during the DNA replication process. DNMT1 also plays an important role in AML, but its function in cytokine-induced memory-like natural killer (CIML NK) cell activity remains unclear.

View Article and Find Full Text PDF

Background: Cytokine-induced killer (CIK) cell therapy has proven successful in clinical trials regarding glioblastoma. Equally important are the hints suggesting peroxisome proliferator-activated receptors (PPARs) ligands being co-expressed in the central nervous system (CNS). This provides a rationale about investigating the possible synergistic effect of CIK cells and PPARs.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to compare the effectiveness of combined therapy with probiotics and cytokine-induced killer (CIK) cells against colorectal cancer (CRC) growth and metastasis in mice versus using either treatment alone.
  • - Results showed that both probiotics and CIK cells significantly reduced CRC cell viability and increased apoptosis, with the combination of both therapies being the most effective at suppressing tumor growth and metastasis.
  • - Mice treated with combined probiotics and CIK therapy exhibited the least amount of tumor presence and related biomarkers in the liver compared to the other treatment groups, indicating a stronger anti-cancer effect.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!